Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 18:14:1266793.
doi: 10.3389/fphar.2023.1266793. eCollection 2023.

Editorial: Curcuminoids: their pleiotropism against hallmarks of cancers

Daniel L Pouliquen  1 , Koraljka Gall Trošelj  2 , Ruby John Anto  3 , Rakesh Naidu  4
Affiliations
Editorial

Editorial: Curcuminoids: their pleiotropism against hallmarks of cancers

Daniel L Pouliquen et al. Front Pharmacol. .
No abstract available

Keywords: clinical trials; combined therapy; curcumin; curcumin analogs; molecular mechanism; molecular targets; nano-formulations; signaling pathways.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Curcuminoids: their pleiotropism against hallmarks of cancers

References

    1. Hopkins A. L. (2008). Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4 (11), 682–690. 10.1038/nchembio.118 - DOI - PubMed
    1. Kuttan R., Sudheeran P. C., Josph C. D. (1987). Turmeric and curcumin as topical agents in cancer therapy. Tumori 73, 29–31. 10.1177/030089168707300105 - DOI - PubMed
    1. Layos L., Martínez-Balibrea E., Ruiz de Porras V. (2022). Curcumin: a novel way to improve quality of life for colorectal cancer patients? Int. J. Mol. Sci. 23, 14058. 10.3390/ijms232214058 - DOI - PMC - PubMed
    1. Lu K.-H., Lu P. W.-A., Lin C.-W., Yang S.-F. (2023). Curcumin in human osteosarcoma: from analogs to carriers. Drug Discov. Today 28, 103437. 10.1016/j.drudis.2022.103437 - DOI - PubMed
    1. Nair S. K., Jez J. M. (2020). Natural product biosynthesis: what’s next? An introduction to the JBC reviews thematic series. J. Biol. Chem. 295 (2), 335–336. 10.1074/jbc.REV119.011586 - DOI - PMC - PubMed

Publication types

LinkOut - more resources